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Developmental Regulation of B Lymphocyte Immune
Tolerance Compartmentalizes Clonal Selection from
Receptor Selection
1995) resulting in down-regulation of V(D)J recombina-
tion that prevents further H chain rearrangements and
insures ªallelic exclusion,º i.e., that the B cell expresses
only one of its two potential H chain gene alleles (Storb
et al., 1994). PreBCR signaling also results in a burst
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(Rolink et al., 1994). Rapidly proliferating preB cells then²Department of Immunology
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to initiate immunoglobulin light (L) chain gene re-Denver, Colorado 80220
arrangements (Constantinescu and Schlissel, 1997) that
fuse VL elements to JL elements (Boekel et al., 1995).
Like H chain gene assembly, this process is both tightly
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regulated and error prone. Inability to complete func-
tional L chain gene rearrangement at this stage resultsB lymphocyte development is a highlyordered process
in developmental arrest and subsequent cell deaththat involves immunoglobulin gene rearrangements,
(Spanopoulou et al., 1994; Young et al., 1994). Success-
antigen receptor expression, and a learning process
ful L chain gene expression permits surface IgM (sIgM)
that minimizes the development of cells with reactivity
expression and differentiation to maturity, a process
to self tissue. Two distinct mechanisms for immune that involves feedback suppression of further V(D)J re-
tolerance have been defined that operate during early combination (Hardy et al., 1991; Storb et al., 1994;
bone marrow stages of B cell development: apoptosis, Boekel et al., 1995), and is followed by the appearance
which eliminates clones of cells, and receptor editing, on the cell surface of a host of differentiation markers
which spares the cells but genetically reprograms their such as IgD, CD21, and CD23 (Hartley et al., 1993; Hardy
autoreactive antigen receptors through nested immu- and Hayakawa, 1995).
noglobulin L chain gene rearrangements. We show With the expression of sIgM and resultant acquisition
here that sensitivity to antigen-induced apoptosis of antigenspecificity, maturing B cells become suscepti-
arises relatively late in B cell development and is pre- ble to immune tolerance (Nossal, 1994; Goodnow, 1996;
ceded by a functionally distinct developmental stage Klinman, 1996; Monroe, 1996), which is probably impor-
capable of receptor editing. This regulation compart- tant in limiting autoantibody production that can lead
mentalizes clonal selection from receptor selection. to disease (Radic and Weigert, 1995). Two concepts
have dominated the thinking about immune tolerance
Introduction in B lymphocytes. One postulates that developing lym-
phocytes pass through a tolerance-susceptible stage in
B lymphocyte development in the bone marrow (BM) is which antigens encounter leads to deletion or functional
characterized by essential and often irreversible changes inactivation; cells progressing through this stage in the
in gene expression that are guided in large part by sig- absence of antigens then lose tolerance sensitivity and
naling through the antigen (Ag)-specific receptors (re- acquire antigen-inducible effector function (Lederberg,
viewed in Rajewsky, 1996). Immunoglobulin (Ig) genes 1959). The second idea is that B cells require two induc-
are rearranged and assembled in a quasiordered cas- tive signals to become activated, one provided by anti-
cade that is regulated both by the expression of the gen-binding to the BCR and a second provided by a
recombinase activator genes RAG1 and RAG2 (Gra- helper T cell (Bretscher and Cohn, 1970). Experimental
wunder et al., 1995) and by receptor gene accessibility to data generated over the years have suggested that both
recombination (Sleckman et al., 1996). Immunoglobulin of these models are partly valid, as immature B cells
gene assembly starts at the heavy (H) chain loci with are particularly tolerance susceptible but can be stimu-
ligation of DH to JH gene segments, followed by VH-to-DJ lated to effector function with strong costimulus (Metcalf
and Klinman, 1977; Pike et al., 1980; Nossal, 1983; Klin-assembly (Tonegawa, 1983; Hardy et al., 1991; Boekel et
man, 1996), whereas mature B cells can be eliminatedal., 1995). As this process is error prone, often leading to
by a strong BCR signal that occurs in the absence ofout-of-frame or incomplete rearrangements (Tonegawa,
an appropriate costimulus (Russell et al., 1991; Parry et1983), expression of productive V-D-J genes is moni-
al, 1994; Tsubata et al., 1994; Finkelman et al., 1995).tored by the cell through the ability of H chain protein to
Furthermore, mature and immature B cells differ bio-assemble ina preB cell receptor (BCR) complex together
chemically in BCR-signaling responses (Monroe, 1996).with l5 and VpreB proteins (ªsurrogate L chainº) (Melch-
Early in vitro studies analyzing the mechanisms for theers et al., 1995; Burrows and Cooper, 1997), which ap-
increased tolerance sensitivity of immature B cells foundpear to have a chaperone function (Shaffer and Schlissel,
that BM or fetal B cells treated with anti-IgM did not1997) allowing plasma membrane deposition. Signaling
rapidly die but lost sIgM expression that was never com-through the preBCR is transduced through associated
pletely restored upon reculture without anti-IgM, whereasIg-a and Ig-b molecules (Melchers et al., 1994; Reth,
similarly treated splenic B cells completely recovered
sIgM expression (Raff et al., 1975; Sidman and Unanue,
1975). Analysis of tolerance in mice bearing autoantigen³To whom correspondence should be addressed.
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transgenes showed that in the presence of membrane-
bound autoantigens mature B cells were eliminated,
while immature B cells bearing a low level of sIgM were
abundant in the BM (Nemazee and Burki, 1989; Hartley
et al., 1991). In these transgenic (Tg) models, autoanti-
gen binding to sIgM on developing B cells blocks their
further development but fails to induce rapid cell loss
and is reversible upon antigen removal (Hartley et al.,
1993; Melamed and Nemazee, 1997). Recent studies
show that the tolerance-induced developmental block
results in continued L chain gene rearrangements in
sIgM1 cells (Hertz and Nemazee, 1997; Melamed and
Nemazee, 1997), violating a strict feedback suppression
model for L chain allelic exclusion. Importantly, this so- Figure 1. Expression of RAG2 Gene in IgMlo/IgD2 but Not in IgMhi/
called ªreceptor editingº process can reprogram BCR IgD2 BM B Cells
specificity through nested L chain gene rearrangements (A) Normal, non-Tg B cell precursors were grown for 5 days in IL-7
culture, stained for surface expression of IgM and IgD, and sortedthat are capable of substituting one functional L chain for
as shown. Sort purity was .95% (not shown).another, allowing cells whose receptors are successfully
(B) B220 and HSA levels increase with sIgM density in IgM1IgD2 Baltered and that no longer bind to autoantigen to resume
cells as determined by flow cytometry.their maturation program and to survive long term (Gay
(C) RT±PCR analysis of mRNA expression of RAG2 in IgMlo/IgD2
et al., 1993; Tiegs et al., 1993; Radic and Zouali, 1996; and IgMhi/IgD2 B cells. CD19 signal served as internal control. Data
Chen et al., 1997). shown is representative of four different experiments.
Importantly, contrasting studies have shown that im-
mature IgM1/IgD2 B cells have heightened sensitivity
to analyze antigen-specific tolerance mechanisms, weto antigen-induced apoptosis (Nossal, 1994; Norvell et
have been able to define two distinct functional re-al., 1995; Klinman, 1996; Monroe, 1996), a finding that
sponses to autoantigen challenge among the IgM1/IgD2is difficult to reconcile both with the ability of autoanti-
B cells: those that expressed low levels of BCR re-gen to induce receptor editing and with the inability of
sponded with robust receptor editing but little or noBcl-2 overexpression to block immune tolerance at this
apoptosis, while those that expressed high levels ofstage of development in BCR Tg mouse models (Hartley
BCR underwent rapid antigen-induced apoptosis.et al., 1993; Lang et al., 1997). To resolve the apparent
contradiction, we hypothesized that the mechanism of
Resultscentral tolerance in B cells might be under develop-
mental regulation. In the present study, we have tested
Expression of RAG2 Gene in IgMlo/IgD2,the notion that newly generated IgM1/IgD2 B cells in-
but Not in IgMhi/IgD2 B Cellsclude two functionally distinct subpopulations that are
To better define the developmental stages at which cellsdivisible based on BCR expression level into popula-
can undergo receptor editing,we studied B cell develop-tions that respond to antigen stimulation by undergoing
ment in IL-7-containing BM cultures of normal, non-Tgreceptor editing or accelerated apoptosis. To perform
mice. In non-Tg BM cultures most cells lacked sIgM,this analysis, we have relied onan IL-7-driven BM culture
but some B cells matured to the IgM1/D2 and IgM1/D1system that was well described previously (Cumano et
stages (Figure 1A). Among the IgM1/D2 cells there wasal., 1990; Rolink et al., 1991; Billips et al., 1992) and
a broad distribution of IgM levels that was correlatedfurther modified by us (Melamed and Nemazee, 1997;
with the expression of a number of other important sur-Melamed et al., 1997). In these cultures, B-lineage cells
face markers including CD45R(B220) and CD24 (heatgrow robustly and can undergo some differentiation,
stable antigen [HSA]) (Figure 1B). These characteristicsbut V(D)J recombination is suppressed (Melamed et al.,
were consistent with those of ex vivo cells (Hardy et1997) probably because of the nature of the cell cycle
al., 1991). To study whether RAG2 expression, which isregulation of the RAG gene products (Li et al., 1996).
required for V(D)J recombination, is correlated to theSubsequent removal of IL-7 from these cultures pro-
mIgM levels, IgMhi/IgD2 and IgMlo/IgD2 B cell precursorsmotes exit from cell cycle, sIgM expression, differentia-
were sorted as shown in Figure 1A, and RAG2 mRNAtion (which is correlated to the level of BCR expression
levels were determined by RT±PCR (Figure 1C). As[Hardy et al., 1991]) and acquisition of maturation mark-
shown in Figure 1C, RAG2 mRNA was detectable iners such as IgD, CD23, CD21, and L-selectin (Hartley
IgMlo/IgD2 cells but not in IgMhi/IgD2 cells, consistentet al., 1993; Melamed et al., 1997). Although the cells'
with the prediction that high-level, cell-surface IgM ex-survival in the absence of IL-7 is limited, under normal
pression is a either a marker of or a signal for develop-circumstances newly generated IgM1 cells can be fol-
mental progression and recombinase down-regulationlowed for 2±3 days (Rolink et al., 1991, 1993; Melamed
(Hardy et al., 1991; Storb et al., 1994; Boekel et al., 1995).et al., 1997), permitting analysis of central B cell toler-
These results suggested to us that the ability to un-ance in vitro. In these cultures, B-lineage cells from BM
dergo receptor editing in response to autoantigenstimu-of 3±83 md immunoglobulin H 1 L Tg mice grow well,
lation might be lost upon high-level expression of sIgM;and their differentiation and response to antigen-spe-
however, the correlation between sIgM density and re-cific stimulation can be controlled (Melamed and Nem-
azee, 1997; Melamed et al., 1997). Using this system combinase expression was difficult to interpret because
Clonal and Receptor Selection in Immune Tolerance
175
in IgM1/IgD2 cells (Figure 2A, left panel). Cells bearing
the IgMlo/IgD2 and IgMhi/IgD2 phenotypes were sorted
as shown and recultured on S17 stromal cells in the
absence of IL-7 to promote differentiation. Cells were
then stained with fluorescent-labeled monoclonal anti-
bodies (MAb) and analyzed by flow cytometry for the
acquisition of maturation markers. These experiments
demonstrated the predicted precursor/product relation-
ship among these populations (Figure 2A, right four pan-
els): IgMhi/IgD2 cells rapidly expressed IgD (Figure 2A,
top right panels), while IgMlo/IgD2 cells first increased
their IgM levels and then acquired IgD (Figure 2A, lower
right panels). For many cells, at least two days were
required for full differentiation to the IgM1/IgD1 pheno-
type. Consistent with their earlier stage of maturity,
IgMlo/IgD2 expressed lower levels of B220, HSA, and
CD22 relative to the IgMhi/IgD2 cells (Figure 2B). During
culture, acquisition of IgD was accompanied by increas-
ing levels of these markers as well as by the appearance
of the additional maturation markers CD21 and CD23
(data not shown). However, in the presence of antigen
(op42 cells), maturation, as defined by theappearance of
these markers, was inhibited, consistent with previous
reports (Hartley et al., 1991; Melamed and Nemazee,
1997). Subsequent experiments probed the functional
Figure 2. Developmental Progression of 3±83 Tg IgM1IgD2 B Cells differences in immune tolerance responses between
upon Reculture on S17 Stromal Cells in the Absence of IL-7 IgMhi/IgD2 and IgMlo/IgD2 subpopulations.
(A) 3±83 Tg BM cells were grown in IL-7, stained for surface expres-
sion of IgM and IgDa, and sorted as shown (left). Sorted cells were
cultured on S17 stroma in complete medium lacking IL-7 for 24±48
Self-Antigen Induces Receptor Editing in 3±83 Tghr, collected, and restained for sIgM and sIgD.
IgMlo/IgD2 and Rapid Apoptosis(B) Flow cytometry analysis of cell surface marker expression on
in IgMhi/IgD2 B Cellssorted IgMlo/IgD2 and IgMhi/IgD2 populations.
We next assessed the ability of antigen binding to the
3±83 Tg BCR to stimulate markers of receptor editingB cells in these normal, non-Tg cultures must rearrange
in the IL-7 BM culture-derived IgMhi/IgD2 and IgMlo/IgD2immunoglobulin genes to generate receptors and their
cells. Upon exposure to the stromal cell line op42, whichreceptor specificities are unknown and heterogeneous,
expresses on its surface MHC antigens to which thegenerating an unknown frequency of autoreactive cells
3±83 BCR reacts, sorted IgMlo/IgD2 cells responded bythat might interact with ligands present in the cultures.
rapid and substantial increases in RAG2 mRNA levelsDifferences in RAG mRNA levels in IgMlo/IgD2 and IgMhi/
(Figure 3A, left). RAG2 levels increased 7-fold after 24IgD2 cell populations could also reflect the levels of
hr and peaked at 14-fold after 48 hr. Antigen stimulationsort contamination by preB cells or the specific down-
of the IgMlo/IgD2 cells also induced new Vk-to-Jk1 Lregulation of sIgM in autoreactive B cells undergoing
chain gene rearrangements, which became evident byreceptor editing. To simplify the analysis, subsequent
48 hr (Figure 3A, right), demonstrating that the RAG geneexperiments used BM from BCR Tg mice. The advantage
up-regulation was functionally relevant. In contrast,of this approach is that all cells have preformed genes
IgMhi/IgD2 cells failed to significantly up-regulate theseencoding a receptor of known specificity that sup-
markers of receptor editing in the first 24 hr (Figure 3A,presses endogenous rearrangements in the absence of
left and right). As less than 10% of the IgMhi/IgD2 cellsantigens.
cultured on op42 were recovered after 48 hr (see below),
receptor editing markers were not tested in these cells3±83 Tg IgMlo/IgD2 B Cells Develop In Vitro
at this time point. The finding that sorted IgMlo/IgD2in the Absence of Antigen and Acquire
cells incubated on S17 had low recombinase activityMaturation Markers
indicated that the antibodies used to stain cells for sort-To determine if IgM levels distinguish B cell populations
ing were insufficient to stimulate significant receptorthat could respond to self-antigen by receptor editing
editing. Overall, thesedata suggested that receptor edit-or apoptosis, we chose to analyze cultures derived from
ing was antigen inducible in IgMlo/IgD2 cells, but not inBM of 3±83 immunoglobulin Tg mice, which have a BCR
IgMhi/IgD2 cells.of known specificity that reacts with certain alleles of
We next assessed the effect of antigen on the survivalmouse class I major histocompatibility complex (MHC)
and apoptosis of the IgMhi/IgD2 and IgMlo/IgD2 cells.antigens (Russell et al., 1991). Because of the effect
These sorted IgM1/IgD2 populations survived well whenof the immunoglobulin transgenes (Spanopoulou et al.,
recultured for 24 hr on S17 stromal cells, which lack1994; Melamed et al., 1997), few sIgM2 cells were pres-
cognate antigens reactive with the 3±83 BCR (Figureent in these cultures but, like cultures derived from non-
Tg BM, they contained IgM1/D1 cells and were enriched 3B, left panels). In contrast, 42.5% of the IgMhi/IgD2 cells
Cell
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Figure 4. Enforced Expression of Bcl-2 Protects IgMhi/IgD2 B Cells
from Antigen-Induced Apoptosis
3±83/Bcl-2 double Tg IgMhi/IgD2 (A±C) and IgMlo/IgD2 (D±F) B cells
were isolated as in Figure 2 and cultured for 24±48 hr on irradiated
layers of S17 stroma (A and D) or op42 stroma (B, C, E, and F). The
presence of apoptotic cells was determined by a TUNEL assay,
and data shown is representative of three different experiments. In
control cultures treated with 5 mM Beauvericin (Sigma), 80%±90%
of the cells were apoptotic.
Fab or IgG anti-IgM behaved similarly in this assay (not
shown). In contrast to the IgMhi/IgD2 cells, IgMlo/IgD2
cells were resistant to antigen-induced apoptosis (Fig-
ure 3B, lower right panel). These data demonstrated that
sIgM density was inversely correlated with the ability to
undergo antigen-induced receptor editing and directly
correlated with the ability to undergo apoptosis: IgMhi/
IgD2 cells were receptor editing-incompetent and apo-
ptosis-sensitive, whereas IgMlo/IgD2 cells were receptor
editing competent and apoptosis resistant. As sIgM ex-
pression is also correlated to developmental progres-Figure 3. Self-Antigen Stimulation of 3±83 Tg B Cell Cultures In-
duces Secondary Rearrangements in IgMlo/IgD2 Cells and Apo- sion, these results suggested that as the B cells ad-
ptosis in IgMhi/IgD2 Cells vanced in development their competence to undergo
IgMlo/IgD2 and IgMhi/IgD2 cells were sorted from 3±83 Tg BM cul- tolerance-induced receptor editing decreased, whereas
tures as in Figure 2 and recultured with S17 or op42 stroma in the sensitivity to antigen-mediated death signals increased.
absence of IL-7.
(A) Left panel, RT±PCR analysis of mRNA expression of RAG2 nor-
malized to that of CD19. Results are shown as mean 6 SEM of three
IgMhi/IgD2 B Cells Protected from Antigen-Inducedseparate experiments. Right panel, DNA PCR analysis of Vk-to-Jk1
rearrangements in cell lysates normalized to that of the 3±83 Tg H Apoptosis by Enforced Bcl-2 Expression
chain gene, Vgam 3.8-JH2. Results are shown as mean 6 SEM of Do Not Undergo Receptor Editing
three separate experiments. Asterisk, values were not determined To determine if the inability of IL-7 BM culture-derived
because of excessive cell death in these samples.
IgMhi/IgD2 cells to undergo receptor editing upon anti-(B) 3±83 Tg IgMhi/IgD2 (upper panels) and IgMlo/IgD2 (lower panels)
gen stimulation was simply the result of their prematureB cells were sorted as in Figure 2 and recultured for 24 hr in the
absence of IL-7 on irradiated S17 (left panels) or op42 (right panels) death, apoptosis in these cells was suppressed through
stroma. The presence of apoptotic cells was quantified by a TUNEL the introduction of a constitutively expressed Bcl-2
assay. In control cultures in which apoptosis was induced with 5 transgene. That this experimental maneuver was suc-
mM Beauvericin, 80%±90% of the cells were apoptotic.
cessful is illustrated in Figure 4, which shows that IgMhi/
IgD2 cells from 3±83/Bcl-2 double Tg BM cultures were
apoptosis resistant upon prolonged exposure to antigenexposed to antigen-bearing op42 cells were apoptotic
(compare Figures 4B and 4C to Figure 3B, top rightat 24 hr as determined by TUNEL assay (Figure 3B, top
panel). Control cultures of IgMhi/IgD2 cells cultured with-right). At 48 hr, fewer than 10% of the IgMhi/IgD2 cells
out antigen on S17 cells (Figure 4A) had low levels ofcultured on op42 were recovered as viable cells com-
apoptosis, as expected, and inclusion of the apoptosis-pared to 60%±70% recovery in the other cultures, indi-
inducing drug Beauvericin resulted in .80% apoptosiscating that most of the antigen-treated IgMhi/IgD2 cells
(data not shown), indicating the efficiency of the assay.underwent antigen-induced programmed cell death by
Using cells from these 3±83/Bcl-2 double Tg cultures,48 hr (data not shown). The observed lack of apoptosis
it was also found that op42-exposed IgMlo/IgD2 cellsof the IgMhi/IgD2 cells in the S17 cultures, combined with
(Figures 4E and 4F) were apoptosis resistant, as wastheir death in op42-containing cultures, again suggested
expected from the results with cultures from 3±83 cellsthat the sorting antibodies had little functional effect on
apoptosis in the subsequent cultures; cells sorted using lacking the Bcl-2 transgene.
Clonal and Receptor Selection in Immune Tolerance
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Figure 5. IgMhi/IgD2 B Cells from 3±83/Bcl-2 Double Tg BM Cultures
Fail to Undergo Receptor Editing in the Presence of Self-Antigen
IgMhi/IgD2 and IgMlo/IgD2 3±83/Bcl-2 double Tg B cells were sorted
from IL-7 BM cultures and recultured without IL-7 on S17 or op42
stroma.
(A) RT±PCR analysis of mRNA expression of RAG2 normalized to
that of CD19. Results are shown as mean 6 SEM of three separate
experiments.
(B) DNA PCR analysis of Vk-Jk1 rearrangements in cell lysates nor-
malized to that of the 3±83 H chain transgene Vgam3.8-JH2. Results
are shown as mean 6 SEM of three separate experiments.
The ability of the Bcl-2 transgene to rescue IgMhi/
IgD2 cells from op42-induced apoptosis allowed us to
determine if this antigenic stimulus resulted in a receptor
editing response. Figure 5 shows that, despite their re-
sistance to apoptosis, 3±83/Bcl-2 double Tg IgMhi/IgD2
cells failed to significantly up-regulate either RAG2 ex-
pression (Figure 5A) or L chain gene recombination in
response to antigenic stimulation (Figure 5B). In con-
trast, 3±83/Bcl-2 double Tg IgMlo/IgD2 cells expressed
a significant 12- to 15-fold increase in RAG2 mRNA and
up to a 3-fold increase in Vk-Jk1 DNA rearrangements
when cultured on op42 for 24±48 hr (Figures 5A and 5B,
respectively). These results suggested that the apoptosis
sensitivity of IgMhi/IgD2 cells was independent of their
loss of competence to undergo receptor editing and
that both of these functional responses were correlated
with developmental progression.
Figure 6. Induction and Functional Consequences of Ca21 Mobiliza-
tion in IgMhi/IgD2 and IgMlo/IgD2 B Cells
The Differential Functional Responses of IgMlo/IgD2
(A) Sorting of B220lo/IgD2 and B220hi/IgD2 subsets. Left panel, sort-
and IgMhi/IgD2 3±83 Tg B Cells to BCR ing gates; right panel, sIgM expression levels in the sorted popula-
Cross-linking Do Not Result from tions.
(B) IgMhi/IgD2 and IgMlo/IgD2 cells have similar Ca21 responses toDifferences in BCR-Mediated
BCR stimuli. 3±83 Tg B cells generated in IL-7 cultures were stimu-Ca21 Mobilization
lated with either 500 ng/ml of antigen coupled to dextran, anti-IgMWe next studied the possibility that the differential re-
MAb (b-7±6) at 1 or 5 mg/ml, or with ionomycin, and mean intracellu-
sponses of IgMlo/IgD2 and IgMhi/IgD2 cells to antigen lar free calcium concentration was evaluated in gated B220lo/IgD2
stimuli resulted from distinct Ca21 mobilization responses and B220hi/IgD2 cells.
as a consequence of quantitative differences in BCR (C and D) Receptor editing and apoptosis in ionomycin-stimulated
IgMhi/IgD2 and IgMlo/IgD2 cells. IgMlo/IgD2 and IgMhi/IgD2 cells wereexpression rather than differentiation status. In order to
sorted from 3±83 Tg BM cultures as in Figure 2 and recultured onidentify these cell populations without perturbing sIgM,
S17 stroma with 0.01±1 mM of ionomycin. Cells were collected afterwe took advantage of the fact that in these cells CD45R
16 hr and RAG2 expression (C) and apoptosis (D) were determined.(B220) expression level is correlated to sIgM density
(Figure 6A). We therefore used B220 levels to gate IgMlo/
IgD2 and IgMhi/IgD2 cells responding to different stimuli antigen coupled to dextran, or ionomycin. Figure 6B
shows that B220lo/IgD2 and B220hi/IgD2 cells underwentthrough the BCR. IL-7 BM culture-derived 3±83 Tg B
cells were stained for IgD and B220, loaded with Indo- similar Ca21 mobilization responses to the different stim-
uli tested in this experiment. Therefore, with respect to1AM, and stimulated with anti-IgM MAb, 3±83 cognate
Cell
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their Ca21 response, which represents an early event IgD2 cells die rapidly. We therefore suggest that recep-
tor editing in B cells is developmentally regulated andin BCR signaling, the cell populations appeared to be
identical despite expression of different amounts of re- that B cells advancing in their development lose the
ability to undergo receptor editing and concomitantlyceptor.
acquire sensitivity to antigen-mediated apoptosis.
Our interpretation of thedata is illustrated in the modelCa21 Mobilization Induces, Respectively, RAG2
presented in Figure 7A. A newly emerging IgMlo/IgD2 cellExpression and Apoptosis in IgMlo/IgD2
that is generated from a preB cell retains the signalingand IgMhi/IgD2 B Cell Populations
properties of a preB cell, including competence to ex-To determine if the differential responses of IgMlo/IgD2
press recombinase and to rearrange L chain genes.and IgMhi/IgD2 B cells were caused by differences in
When such a cell encounters autoantigen, survival ismaturational status or BCR level, we tested whether or
not immediately impaired (this study; Hartley et al., 1993;not these cell populations responded differently to an
Hertz and Nemazee, 1997; Melamed and Nemazee,intracellular signaling stimulus that should bypass the
1997), but VLJL recombination persists as a result ofBCR and trigger an equivalent Ca21 response. We cul-
developmental arrest, resulting in receptor editing. If thetured sorted IgMlo/IgD2 and IgMhi/IgD2 3±83 Tg B cells
IgM receptors expressed bya receptor editing±competentfor 16 hr on S17 stroma in the presence of 0.01±1 mM
B cell fail to bind antigens, the cell eventually undergoes
ionomycin and then assayed for RAG2 mRNA up-regula-
a critical decision committing it to its receptor. This
tion as a marker for receptor editing (Figure 6C) and
commitment is comprised of further differentiation to
apoptosis (Figure 6D). Low doses of ionomycin stimula-
receptor editing incompetence and apoptosis hyper-
tion (0.01±0.1 mM), which stimulated a low-level Ca21
sensitivity. This now-committed B cell should generally
response (Figure 6B), efficiently induced 3- to 4-fold
have higher sIgM density than an immature B cell and,increases in RAG2 gene expression in IgMlo/IgD2 cells in
if it subsequently encounters autoantigen, will also lackthe absence of cell death (Figures 6C and 6D). Similarly
the ability to undergo receptor editing, but insteadtreated IgMhi/IgD2 cells did not expresssignificant levels
should rapidly undergo apoptosis (Figure 3B). Theseof RAG2 mRNA (Figure 6C), despite their similar Ca21
cells probably correspond to the ªtransitionalº B cellsinflux response, and were more sensitive to apoptosis
described by several investigators, which die rapidlyat the same ionomycin concentrations (Figure 6D). At
when acutely treated with antigens or anti-BCR anti-high doses of ionomycin, RAG2 expression was dimin-
bodies (Brines and Klaus, 1992; Carsetti et al., 1995;ished in IgMlo/IgD2 cells and increased apoptosis was
Norvell et al., 1995; Monroe, 1996). Assuming that this
monitored in both cell populations, consistent with the
scenario is correct, it implies that most B cell tolerance
possibility that high concentrations of ionomycin are
naturally occurring in the BM (central tolerance) should
toxic. It is also possible that high doses of ionomycin
be through the mechanism of receptor editing, because
might stimulate cell cycle events, which are known to
cells at this site are unlikely to mature to the ªcommitted
down-regulate RAG expression (Li et al., 1996). Thus,
B cellº stage in the presence of antigens (Hartley et al.,upon BCR-independent Ca21 mobilization, IgMlo/IgD2 B
1993; Tiegs et al., 1993; Melamed and Nemazee, 1997).cells were more competent to undergo receptor editing
Consistent with this prediction, receptor editing is ex-than IgMhi/IgD2 cells, suggesting that the differential
tensive in mice with germline-targeted anti-DNA or anti-responses of the IgMlo and IgMhi populations were the
MHC class I autoantigen genes in the natural genomicresult of developmental differences rather than distinct
context, and, as a consequence, peripheral B cell num-signaling responses of cells at a single stage of differen-
bers are not drastically reduced (Chen et al., 1997; Pel-tiation. Finally, these results demonstrated that Ca21
anda et al., 1997). However, because of the error-pronemobilization following BCR cross-linking is likely re-
nature of V(D)J recombination, cells undergoing recep-sponsible for both receptor editing and apoptotic re-
tor editing are not always able to correct their autoreac-
sponses.
tive antigen receptors to relieve their arrested develop-
ment and eventually die by default, probably at a rate
Discussion characteristic of preB cells that fail to generate func-
tional L chains (Lu and Osmond, 1997). Cells at the IgM1/
Receptor Editing and Apoptosis Sensitivity IgD2 stage have little or no expression of the important
Are Developmentally Regulated death inhibitory proteins Bcl-2 and Bcl-x (Li et al., 1993;
This paper attempts to integrate two opposing lines Choi et al., 1996), which are highly expressed in other
of evidence about the mechanisms of central B cell B cell developmental stages and are required for normal
tolerance: one indicating that receptor editing and de- lymphoid development and maintenance (Nakayama et
velopmental arrest are the dominant responses (Gay et al., 1993; Veis et al., 1993; Rajewsky, 1996). On the other
al., 1993; Tiegs et al., 1993; Radic and Zouali, 1996; Hertz hand, committed B cells should be permitted to exit to
and Nemazee, 1997; Melamed and Nemazee, 1997), the the periphery where they would undergo an apoptotic
other indicating that apoptosis can be a major mecha- or anergy response when they encounter autoantigens
nism (Nossal, 1994; Goodnow, 1996; Klinman, 1996; not present in the BM (Russell et al., 1991; Goodnow,
Monroe, 1996). The results presented reconcile the dis- 1996; Lang et al., 1997).
parate findings of the prior studies and demonstrate An alternative interpretation of the differential re-
the existence of two sequential differentiation stages sponses of immature and committed B cells to self-
among IgM1/IgD2 cells. We showhere that upon antigen antigen is that they represent distinct signaling re-
binding the newly generated IgMlo/IgD2 cells undergo sponses of a single cell type that are regulated by the
quantitative interactions between antigens and the BCRreceptor editing, whereas the more developed IgMhi/
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179
Figure 7. Alternative Models for the Regulation of Central Tolerance
(A) Developmental model postulates that IgM1IgD2 cells comprise two developmentally distinct compartments that differ in their response
to autoantigen by undergoing either receptor editing (pathway ª1º) or cell death (pathway ª2º). The latter response is blocked by enforced
Bcl-2 expression. It is further postulated that cells undergoing receptor editing fail to progress in development unless they alter their receptors
such that they lose autoreactivity and that cells failing to do so eventually die by default. In this model, the type of tolerance response is
regulated by the developmental stage at which the cell encounters antigen.
(B) Signaling model postulates that the specific interaction between a particular antigen and the levels of signaling molecules, including IgM
and other surface molecules, regulates cell death and receptor editing among IgM1IgD2 cells. This model predicts that a single cell type is
capable of either antigen-induced receptor editing or apoptosis depending on the nature of the antigen stimulus. In this model, the type of
tolerance response is regulated by the nature of the signal elicited by antigen.
(Figure 7B). According to this idea, the nature of the becomes significant (Hertz and Nemazee, 1997). Taken
together, we conclude that the distinction between theantigen,sIgM levels, and perhaps also the levels of asso-
ciated signaling molecules such as CD45R could regu- receptor editing or apoptosis responses in IgM1/IgD2
B cells is not based on distinct signaling responses oflate the BCR signal, which in turn would affect whether
the cell undergoes receptor editing or apoptosis in re- a single cell type, but rather represent a developmentally
regulated change in biologic response.sponse to antigens. The data presented here do not favor
this possibility by showing that both cell types have Our conclusions were reached by taking advantage
of an immunoglobulin Tg mouse strain that allows con-similar Ca21 responses to BCR ligation despite their
differing biological responses. Furthermore, a BCR- trol of BCR specificity and an IL-7 BM culture system
that facilitates the isolation and synchronization of Bindependent, Ca21 mobilization signal (mimicked by
ionomycin treatment) stimulated significant levels of cell differentiation. As these experimental maneuvers
perturb B cell development in several ways and onlyRAG2 mRNA without cell death in IgMlo cells, but not in
IgMhi cells (Figures 6C and 6D). Also arguing against a allow us to follow B cell fate for a limited period of time,
it will be important to confirm these results in a moresimple role for signaling intensity on the commitment to
receptor editing or apoptosis is our finding that a wide physiological system. The use of independent, antigen-
specific BCR Tg mice may help in testing whether theserange of antigenic stimuli can stimulate receptor editing
in immature B cells. For example, different naturally oc- results are generalizable. While the use of non-Tg imma-
ture B cells to study these issues would be ideal, suchcurring MHC class I antigens that bind to the 3±83 recep-
tor with a wide range of affinities can all stimulate recep- an approach is confounded by two problems. The het-
erogeneity of their antigen receptors generates an un-tor editing in vivo (Lang et al., 1996). In addition, titration
experiments usinga wide concentration range of anti-BCR known background frequency and extent of BCR stimu-
lation, and specific stimulation of their antigen receptorsantibodies have failed to define a threshold above which
receptor editing fails to occur or at which apoptosis requires the use of anti-BCR antibodies that may poorly
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mimic natural antigens. Our studies also made use of hand, cells with self-reactive BCRs will fail to receive
positive signals required for maturation and, like preBBCR-reactive antigenthat was expressed at a significant
epitope density on the surface of a stromal cell line. It cells that fail to generate a productive L chain, will con-
tinue to rearrange L chain genes. The present studyremains to be seen if soluble antigen or a lower density
of membrane antigen could drive similar functional re- suggests that this developmental commitment step can
be functionally defined by heightened apoptosis sensi-sponses, although studies using BCR antibodies as sur-
rogate antigens suggest that bivalent ligands of high tivity and by the lossof competence to undergo receptor
editing. These differences in the biological response toaffinity are sufficient for both receptor editing and apo-
ptotic responses. antigen stimulation suggest that as B cells advance in
development the mechanism of immune tolerance prog-
resses from receptor selection to clonal selection.
The BCR Signals Both Positive
and Negative Selection Experimental Procedures
As BCR expression levels increase during B cell devel-
opment (Hardy et al., 1991), we used this marker in the Mice
Mice used for the experiments were strain B10.D2nSn/J that ex-present study to distinguish immature from committed
pressed the 3±83 transgene, which encodes a BCR reactive to theB cells. While we have identified a correlation between
mouse class I MHC antigens Kk and Kb (Russell et al., 1991), or theirsIgM expression and B cell commitment to its receptor,
non-Tg littermates. In some experiments, mice Tg for both the 3±83
it is unclear if sIgM density per se constitutes the signal genes and the Em2±22 Bcl-2 transgene (Lang et al., 1997; Strasser
for B cell commitment, or if it is merely a convenient et al., 1991) were used. Mice were housed and bred at the National
marker. Clearly, some level of sIgM and its consequent Jewish Center facility and used at 4±8 weeks of age.
signaling is required for completion of the later stages
of B cell development, as is indicated by a variety of Cell Culture
B cell precursors from Tg and non-Tg mice were grown in vitro asmutational studies (reviewed in Rajewsky, 1996), sug-
described (Melamed and Nemazee, 1997; Melamed et al., 1997).gesting that in the absence of receptor cross-linking the
Briefly, BM cells were depleted of erythrocytes and were culturedbasal signaling of a high levelof assembled IgM receptor
in IMDM medium (GIBCO-BRL) supplemented with 10% fetal calf
complex could be sufficient to drive developmental pro- serum (Gemini Bio-Products, Calabasas, CA), 5 3 1025 M 2-mercap-
gression (see also Shaffer and Schlissel, 1997). But, in toethanol, and 50±100 U/ml of rIL-7 (Winkler et al., 1995) at a concen-
a diverse repertoire, it is also potentially possible that tration of 2 3 106 cells/ml for 5±6 days. These culture conditions
allow preferential growth of IL-7-responsive B cell precursors, andfor some receptors weak BCR:ligand interactions can
after 5±6 days the culture contains .98% of B2201 cells (Melameddrive development at low surface IgM densities. In the
et al., 1997). Culturedcells were stained and sorted by FACS into twocase of the sorted 3±83 Tg B cells studied here, all cells
populations (see Results). Sortedpopulations were then cultured for
had identical antigen specificity and only sIgM levels 16±48 hr in the absence of IL-7 (conditions that promote differentia-
differed, albeit by only z10-fold. The quantitative differ- tion [Hardy et al., 1991; Rolink et al., 1991, 1993; Melamed et al.,
ences in IgM levels and biological responses among 1997]) on plates with adherent 2000 rad treated antigen-negative
stromal cell line S17 (Cumano et al., 1990) orantigen-bearing stromalthese genetically identical cells is probably attributable
cell line op42 (Smithson et al., 1995). Stromal cell lines were testedto their asynchronous proliferative arrest and subse-
for the expression of the (3±83 BCR-reactive) mouse class I MHCquent developmental progression following IL-7 with-
antigens Kk and Kb by staining with the high-affinity antibody Y3
drawal. The kinetics of development of these two popu- (Lang et al., 1996). The relevant antigen on these cells is the mouse
lations suggested that the IgMlo/IgD2 cells required more MHC class I alloform H-2Kk. In some experiments, sorted cells were
time to acquire sIgD than did the IgMhi/IgD2 cells. Thus, cultured on S17 stroma and stimulated for 16 hr with 0.01±1 mM
ionomycin.it is also possible that the duration of a basal, unligated
sIgM signal could direct developmental progression.
Flow Cytometry and SortingIn this study, we have been able to show that cycling,
Antibodies used for cell staining were: goat anti-mouse IgM-FITCIL-7-responsive BCR Tg cells expressing low levels of
(Zymed, San Francisco, CA), anti-mouse IgDa AMS 9.1-FITC orrecombinase mRNA could be induced to increase dra-
-biotin (Pharmingen), anti-mouse IgD JA12.5-biotin, anti-mouse
matically these levels upon the concerted stimulation CD21 7E9-biotin (Kinoshita et al., 1988), anti-mouse CD22 CY34.1.2-
by specific antigen and IL-7 withdrawal. In normal B biotin (American Type Tissue Culture Collection, Rockville, MD),
cell development, nondividing, recombinationally active anti-mouse B220 RA3±6B2-phycoerythrin (PE) (Pharmingen), goat
anti-mouse IgM-PE (Caltag), and anti-mouse HSA (CD24) M1/69 PEpreB cells give rise to sIgM1 cells (Hardy et al., 1991;
(Pharmingen). Biotinylated antibodies were visualized with Strepta-Boekel et al., 1995). It is therefore likely that self-antigen-
vidin PE (Becton Dickinson) for two-color analysis or with Streptavi-induced receptor editing in normal developing B cells
din-Tri Color (Caltag) for three-color analysis. FACS analysis was
occurs through the maintenance of recombinase rather performed on FACScan (Becton Dickinson) with forward and side-
than its reexpression. This notion implies that the preB scatter gates adjusted to include only nucleated viable cells. For
and immature IgM1 cells constitute a single stage of cell sorting, Tg and non-Tg B cell precursors were collected after
5±6 days of culture and stained for expression of sIgD and sIgMdifferentiation with virtually identical signaling machin-
(or, for the data presented in Figure 6, B220). Based on these twoery and transcriptional control. We are aware of no sur-
markers, IgMhi/IgD2 and IgMlo/IgD2 cell populations were sortedface markers other than sIgM itself that distinguish these
using an Elite flow cytometer (Coulter). Sorted cells were washed
cells. Generation of an appropriate antigen receptor and then cultured as described in Results.
through successful VJ recombination and expression of
L chains that complete a nonautoreactive BCR is an Apoptosis Assay
important signal that permits commitment to maturation Antigen-mediated death of B cell precursors in the cultures was
determined by the terminal deoxynucleotidyltransferase-mediated(Melchers et al., 1995; Rajewsky, 1996). On the other
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uridine triophosphate end labeling (TUNEL) assay (Boehringer Mann- are the target of negative selection in the B cell compartment. J.
Exp. Med. 181, 2129±2140.heim) as described (Melamed and Nemazee, 1997). As a positive
control for the activity of the assay, in each experiment some sam- Chen, C., Prak, E.L., and Weigert, M. (1997). Editing disease-associ-
ples were treated with the apoptosis-inducing drug Beauvericin ated autoantibodies. Immunity 6, 97±105.
(cyclo-[D-a-Hydroxyisovaleryl-L-methylphenylalanyl]3) (Ojciuset al., Choi, M.S., Holmann, M., Atkins, C.J., and Klaus, G.G. (1996). Ex-
1991) (Sigma) at a final concentration of 5 mM. pression of bcl-x during mouse B cell differentiation and following
activation by various stimuli. Eur. J. Immunol. 26, 676±682.
DNA and RNA Analysis
Constantinescu, A., and Schlissel, M.S. (1997). Changes in locus-DNA templates for PCR were prepared in cell lysates as described
specific V(D)J recombinase activity induced by immunoglobulin(Melamed and Nemazee, 1997). cDNA templates were generated
gene products during B cell development. J. Exp. Med. 185,from total RNA purified using the RNAzol method (Tel-Test,
609±620.Friendswood, TX) as described (Melamed and Nemazee, 1997).
Cumano, A., Dorshkind, K., Gillis, S., and Paige, C.J. (1990). TheQuantitation of endogenous Vk-Jk1 rearrangements and of the
influence of S17 stromal cells and interleukin-7 on B cell develop-3±83 H chain transgene (Vgam3.8-JH2) in DNA samples was deter-
ment. Eur. J. Immunol. 20, 2183±2189.mined by a PCR assay. Levels of RAG2 and CD19 mRNA were
determined by a reverse transcriptase (RT)±PCR assay. The PCR Finkelman, F.D., Holmes, J.M., Dukhanina, O.I., and Morris, S.C.
conditions and primer sequences were as described (Melamed and (1995). Cross-linking of membrane immunoglobulin D, in the ab-
Nemazee, 1997). PCR products were fractionated on 1% agarose sence of T cell help, kills mature B cells in vivo. J. Exp. Med. 181,
gels, transferred to nylon membranes, and hybridized with specific 515±525.
RAG2, CD19, Jk, or JH specific probes. Blots were scanned in a Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993). Receptor
Phosphor-Imager (Molecular Dynamics) to quantitate signal inten- editing: an approach by autoreactive B cells to escape tolerance.
sity. The results are expressed as a semiquantitative estimate where J. Exp. Med. 177, 999±1008.
signal intensity of RAG2 product was normalized to that of CD19
Goodnow, C.C. (1996). Balancing immunity and tolerance: deleting
product signal and that of the Vk-Jk1 PCR was normalized to the
and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93,
signal intensity of the Vgam3.8-JH2 (the Tg H chain) product.
2264±2271.
Grawunder, U., Leu, T.M.J., Schatz, D.G., Werner, A., Rolink, A.G.,Analysis of Calcium Mobilization
Melchers, F., and Winkler, T.H. (1995). Down-regulation of RAG1 andIL-7 BM culture-derived 3±83 Tg B cells were surface stained for
RAG2 gene expression in preB cells after functional immunoglobulinB220 (CD45R) and IgDa and subsequently loaded with Indo-1AM
heavy chain rearrangement. Immunity 3, 601±608.(Molecular Probes) for 45 min at 378C. Cells were washed twice and
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